About Divis Laboratories
Divis Laboratories is a company based in Hyderabad (India) founded in 1990 by Murali K Divi. The company has 18,300 employees as of March 31, 2024. Divis Laboratories offers products and services including Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3. Divis Laboratories operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 18300 as on 31 Mar, 2024
- Founders Murali K Divi
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Divi's Laboratories Limited
-
Annual Revenue
$1.1 B (USD)19.48as on Mar 31, 2025
-
Net Profit
$256.46 M (USD)36.94as on Mar 31, 2025
-
EBITDA
$355.83 M (USD)30.47as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
18300
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Divis Laboratories
Divis Laboratories is a publicly listed company on the NSE with ticker symbol DIVISLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Divis Laboratories
Divis Laboratories offers a comprehensive portfolio of products and services, including Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3.
Active ingredient for pain and inflammation relief medications
Cough suppressant used in respiratory treatments
Medication for nerve pain and seizures management
Antioxidant supplement for nutritional health
Essential vitamin for bone health and immunity
People of Divis Laboratories
Unlock access to complete
Funding Insights of Divis Laboratories
Detailed funding history for Divis Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Divis Laboratories
Investment portfolio details for Divis Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Divis Laboratories
Detailed financials for Divis Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Divis Laboratories Comparisons
Peer comparison for Divis Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Divis Laboratories
Divis Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Divis Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Divis Laboratories
Complete news archive for Divis Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Divis Laboratories
Divis Laboratories was founded in 1990.
Divis Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2024, the latest employee count at Divis Laboratories is 18,300.
Annual revenue of Divis Laboratories is $1.1B as on Mar 31, 2025.
Divis Laboratories was founded in 1990 in Hyderabad, India, and operates as a contract manufacturer in the pharmaceutical sector. Synthesis of chiral compounds and protected amino acids is specialized in, along with custom services for APIs and advanced intermediates used in drug discovery. Alternate processes that avoid patent infringement are developed for APIs and intermediates. Operations focus on providing these services to support pharmaceutical development.
Divis Laboratories's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
Divis Laboratories offers Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3.
Yes, Divis Laboratories is publicly traded on NSE under the ticker symbol DIVISLAB.
The ticker symbol of Divis Laboratories is DIVISLAB on NSE.